Skip to main content
Log in

Cirrhosis and diabetes

I. Increased incidence of diabetes in patients with Laennec's cirrhosis

  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Abstract

The frequency of diabetes, defined as persistent fasting hyperglycemia, was evaluated in a consecutive group of 240 cirrhotic patients. A randomly selected group of 411 noncirrhotic patients of similar age, admitted to the hospital during the same period, served as a control group. Diabetes was significantly more common in the cirrhotic group (40 of 240, 16.7%) than in the noncirrhotic group (29 of 411, 7.1%). In the majority, cirrhosis was apparent before the diabetes was detected; in 18% the diabetes was noted first.

The diabetes in the cirrhotic group was maturity-onset in type, characterized by fasting hyperglycemia, minimal glycosuria, relative freedom from vascular complications, and simple management with diet or oral agents. Although the features of cirrhosis were similar in the groups with and without diabetes, a history of diabetes in the immediate family (46 vs 16%) and the presence of portacaval anastomoses (30 vs 13%) were far more common in those with diabetes.

There are many potential diabetogenic factors operative in cirrhosis which may induce diabetes. The appropriate disorders could result in diabetes of hepatogenous, pancreatitic, hemosiderotic, kaliopenic, portal-systemic anastomotic, insulin-resistant, somatotropic, or genetic origin. The data suggest that these factors, acting individually or perhaps in various combinations, may precipitate diabetes in genetically susceptible patients or may even induce diabetes de novo in some cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Naunyn, B. Der Diabetes Mellitus (ed. 2), A. Hölder, Wien, 1906.

    Google Scholar 

  2. Labbe, M., andNepveux, F. Glycémie et é preuve d'hyperglycémie chez les hépatiques.Bull Soc Med Hôp (Paris) 53:329, 1929.

    Google Scholar 

  3. Jaques, W. E. Incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus.New Eng J Med 249:442, 1953.

    Google Scholar 

  4. Poche, R. K., andSchumacher, K. T. Über Zusammenhänge zwischen Diabetes Mellitus und Leberzirrhose.Deutsch Z Verdaustoffwechselkr 16:68, 1956.

    Google Scholar 

  5. Hed, R. Clinical studies in chronic alcoholism. I. Incidence of diabetes mellitus in portal cirrhosis.Acta Med Scand 162:189, 1958.

    Google Scholar 

  6. Creutzfeldt, W. Klinische beziehungen zwischen Diabetes mellitus und Leber.Acta Hepatosplen 6:156, 1959.

    Google Scholar 

  7. Bloodworth, J. M. B. Diabetes mellitus and cirrhosis of the liver.Arch Intern Med 108:695, 1961.

    Google Scholar 

  8. Wantz, G. E., andPayne, M. A. Experience with portacaval shunt for portal hypertension.New Eng J Med 265:721, 1961.

    Google Scholar 

  9. Boulet, P., Mirouze, J., Barjon, P., Fabre, S., andChapel, A. Cirrhoses non-hémochromatosiques et Diabete sucrè (A propos de 25 observations).Diabète 10:51, 1962.

    Google Scholar 

  10. Domart, A., Labram, C., andBerger, R. A propos d'une observation de diabète insulorésistant transitoire compliquant une cirrhose avec hémochromatose secondaire les hyperglycémies des cirrhoses éthyliques.Sem Hôp Paris 40:25, 1964.

    Google Scholar 

  11. Müting, D., Lackas, N., Reikowski, H., andRichmond, S. Cirrhosis of the liver and diabetes mellitus. A study of 140 combined cases.German Med Monthly 11:385, 1966.

    Google Scholar 

  12. Conn, H. O., andLindenmuth, W. W. Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices. Interim results with suggestions for subsequent investigations.New Eng J Med 279:725, 1968.

    Google Scholar 

  13. Yesner, R., andConn, H. O. Liver function tests and needle biopsy in the diagnosis of metastatic cancer of the liver.Ann Intern Med 59:62, 1963.

    Google Scholar 

  14. Fajans, S., andConn, J. W. Diabetes. Williams, R. H., Ed. Hoeber, New York. 1960, p 388.

    Google Scholar 

  15. Rankin, T. J., Jenson, R. L., andDelp, M. Oral glucose tolerance as a test of liver function.Gastroenterology 25:548, 1953.

    Google Scholar 

  16. Debry, G., andCharles, J. Etude des perturbations du métabolisme des glucides chez les sujets attemts de cirrhose hépatique.Diabète 13:151, 1965.

    Google Scholar 

  17. Schreiber, W. M., andConn, H. O. Glucose tolerance in cirrhosis of the liver.Ann Intern Med 66:1032, 1967.

    Google Scholar 

  18. Megyesi, C., Samols, E., andMarks, V. Glucose tolerance and diabetes in chronic liver disease.Lancet 2:1051, 1967.

    Google Scholar 

  19. Nilsson, S. E. Genetic and constitution aspects of diabetes mellitus.Acta Med Scand 375 (Supp.):1, 1962.

    Google Scholar 

  20. The family history of diabetes: Report of a working party appointed by the college of general practitioners.Brit Med J 1:960, 1965.

    Google Scholar 

  21. Duncan, G. G. “Early clinical picture of diabetes.” InDiabetes Williams, R. H., Ed. Hoeber, New York, 1963, p 370.

    Google Scholar 

  22. Kalk, H. The relationship between fatty liver and diabetes mellitus.German Med Monthly 5:81, 1960.

    Google Scholar 

  23. Knick B., Lange, H. J., andHeckmann, K. Correlation between latent diabetes mellitus, obesity and fatty liver.German Med Monthly 11:149, 1966.

    Google Scholar 

  24. Rubin, E., andLieber, C. S. Alcohol induced hepatic injury in non-alcoholic volunteers.New Eng J Med 278:869, 1968.

    Google Scholar 

  25. Klatskin, G. Alcohol and its relation to liver damage.Gastroenterology 41:443, 1961.

    Google Scholar 

  26. Seige, K. Untersuchungen über Leberfunktionsstörungen und Leberkrankungen bei Diabetes mellitus.Dtsch Z Verdau Stoffwechselkr 21:128, 1961.

    Google Scholar 

  27. Franken, F. H., Amelung, D., Garke, P., Pohle, D., Liebermeister, H., andDeupmann, F. J. Post-hepatitic cirrhosis of the liver. A follow-up study.German Med Monthly 12:305, 1967.

    Google Scholar 

  28. Twiss, J. R., andCarter, R. F. The relationship of biliary tract disorders to diabetes mellitus.Amer J Med Sci 224:263, 1952.

    Google Scholar 

  29. Conn, J. W., Newburgh, L. H., Johnstone, M. W., andSheldon, J. M. Study of the deranged carbohydrate metabolism in chronic infectious hepatitis.Arch Intern Med 62:765, 1938

    Google Scholar 

  30. Leevy, C. M., Fineberg, J. C., White, T. J., andGnassi, A. M. Hyperglycemia and glycosuria in the chronic alcoholic with hepatic insufficiency. Clinical observations in 10 patients.Amer J Med Sci 223:88, 1952.

    Google Scholar 

  31. Sobel, H. J., andWayne, J. D. Pancreatic changes in various types of cirrhosis in alcoholics.Gastroenterology 45:341, 1963.

    Google Scholar 

  32. Goidsenhoven, G. E., van Henke, W. J., Vacca, J. B., andKnight, W. A. Pancreatic function in cirrhosis of the liver.Amer J Dig Dis 8:160, 1963

    Google Scholar 

  33. Sprague, R. G. Diabetes mellitus associated with chronic relapsing pancreatitis.Mayo Clin Proc 22:553, 1947.

    Google Scholar 

  34. Bell, E. T. Pancreatitis. I. Study of 179 fatal cases.Surgery 43:527, 1958.

    Google Scholar 

  35. Ohlsen, P. Endocrine and exocrine pancreatic function in pancreatitis.Acta Med Scand 484 (Supp.):I, 1968.

    Google Scholar 

  36. Peters, N., Dick, A. P., Hales, C. N., Orrell, D. H., andSarner, M. Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis.Gut 7:277, 1966.

    Google Scholar 

  37. Moretti, G., Geyer, A., andDucloux, M. Le pancreas dans les cirrhosis alcooliques.Pressé Med 64:376, 1951.

    Google Scholar 

  38. Kinnear, T. W. G. The pattern of diabetes mellitus in a Nigerian teaching hospital.E Afr Med J 40:288, 1963.

    Google Scholar 

  39. Williams, R., Williams, H. S., Scheuer, P. J., Pitcher, C. S., Loiseau, E., andSherlock, S. Iron absorption and siderosis in chronic liver disease.Quart J Med 36:151, 1967.

    Google Scholar 

  40. Tuttle, S. G., Figueroa, W. G., andGrossman, M. I. Development of hemochromatosis in patients with Laennec's cirrhosis.Amer J Med 26:655, 1959.

    Google Scholar 

  41. Ecker, J. A., Gray, P. A., McKittrick, J. E., andDickson, D. R. The development of postshunt hemochromatosis-parenchymal siderosis in patients with cirrhosis occurring after postasystemic shunt surgery.Amer J Gastroent 50:13, 1968.

    Google Scholar 

  42. Davis, A. E., andBadenoch, J. Iron absorption in pancreatic disease.Lancet 2:6, 1962.

    Google Scholar 

  43. Conn, J. W. Hypertension, the potassium ion and impaired carbohydrate tolerance.New Eng J Med 273:1135, 1965.

    Google Scholar 

  44. Breckenridge, A., Welborn, T. A., Dollery, C. T., andFraser, R. Glucose tolerance in hypertensive patients on long-term diuretic therapy.Lancet 1:61, 1967.

    Google Scholar 

  45. Brown, W. J., Jr, andBrown, F. K. Thiazide-induced alteration of carbohydrate tolerance in normal men.Curr Ther Res 9:200, 1967.

    Google Scholar 

  46. Sagild, U., Andersen, V., andAndreasen, P. B. Glucose tolerance and insulin responsiveness in experimental potassium depletion.Acta Med Scand 169:243, 1961.

    Google Scholar 

  47. Spergel, G., Bleicher, S. J., Goldberg, M., Adfsman, J., andGoldner, M. G. The effect of potassium on impaired glucose tolerance in chronic uremia.Metabolism 16:581, 1967.

    Google Scholar 

  48. Wolff, F. W., andParmley, W. W. Further observations concerning the hyperglycemic activity of benzothiadizines.Diabetes 13:115, 1964.

    Google Scholar 

  49. Rapoport, M. I., andHurd, H. F. Thiazide-induced glucose intolerance treated with potassium.Arch Intern Med 113:405, 1964.

    Google Scholar 

  50. Slayton, P. E., andBiglieri E. C. Hypertension and hyperaldosteronism of renal and adrenal origin.Amer J Med 38:324, 1965.

    Google Scholar 

  51. Perkins, K. W., andConn, H. O. Unpublished data.

  52. Hearn, G. W. Development of diabetes mellitus after portacaval anastomosis.Brit Med J 2:96, 1963.

    Google Scholar 

  53. Christensen, M. F. Diabetisk stofskifteanomali efter portosystemisk shunt.Ugeskr Laeg 129:195, 1967.

    Google Scholar 

  54. Hermann, G., Witten, T. A., andStarzl, T. E. Evaluation of portacaval shunt patency with the differential glucose tolerance test.Surg Gynec Obstet 116:285, 1963.

    Google Scholar 

  55. Billings, F. T., andDePree, H. E. Diagnosis of portal vein obstruction. Studies of intestinal absorption of glucose using abdominal collateral veins.Bull Johns Hopkins Hosp 85:183, 1949.

    Google Scholar 

  56. Unger, R. H., Ohneda, A., Valnerde, I., Eisentraut, A. M., andExton, J. Characterization of the responses of circulating glucagon-like immuno-reactivity to intraduodenal and intravenous administration of glucose.J Clin Invest 47:48, 1968.

    Google Scholar 

  57. Creutzfeldt, W., Wille, K., andKaup, H. Intravenöse belastungen mit glucose insulin und tolbutamid bei gesunden, diabetikern, leberzirrhotikern und insulomträgern.Deutch Med Wschr 87:2189, 1962.

    Google Scholar 

  58. Felber, P. J.-P., Magnenat, P., andVannotti, A. Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose.Schweiz Med Woch 97:1537, 1967.

    Google Scholar 

  59. Conn, H. O. Cirrhosis and diabetes. III. Insulin secretion in Laennec's cirrhosis. In press.

  60. Mortimore, G. E., andTietze, F. Studies on the mechanism of capture and degradation of insulin-I131 by the cyclically perfused rat liver.Ann NY Acad Sci 82:329, 1959.

    Google Scholar 

  61. Samols, E., andRyder, J. A. Studies on tissue uptake of insulin in man using a differential immunoassay for endogenous and exogenous insulin.J Clin Invest 40:2092, 1961.

    Google Scholar 

  62. Wajchenberg, B. L., Hoxter, G., Mello, E. L. H., andUlhoa Cintra, A. B. Nonesterified and esterified fatty acids in hepatocellular disease.Lancet 1:1218, 1960.

    Google Scholar 

  63. Mortiaux, A., andDawson, A. M. Plasma free fatty acid in liver disease.Gut 2:304, 1961.

    Google Scholar 

  64. Karam, J. H., Grodsky, G. M., andForsham, P. H. Excessive insulin response to glucose in obese subjects as measured by immuno-chemical assay.Diabetes 12:197, 1963.

    Google Scholar 

  65. Beck, P., Koumans, J. H. T., Winterling, C. A., Stein, M. F., Daughaday, W. H., andKipnis, D. M. Studies of insulin and growth hormone secretion in human obesity.J Lab Clin Med 64:654, 1964.

    Google Scholar 

  66. Burt, R. L. Peripheral utilization of glucose in pregnancy. III. Insulin tolerance.Obstet Gynec 7:658, 1956.

    Google Scholar 

  67. Kalkhoff, R., Schalch, D. S., Walker, J. L., Beck, P., Kipnis, D., andDaughaday, W. H. Diabetogenic factors associated with pregnancy.Trans Ass Amer Physicians 77:270, 1964.

    Google Scholar 

  68. Schalch, D. S., andKipnis, D. M. Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids.J Clin Invest 44:2010, 1965.

    Google Scholar 

  69. Greenough, W. B., III, Crespin, S. R., andSteinberg, D. Hypoglycaemia and hyperinsulinaemia in response to raised free-fatty-acid levels.Lancet 2:1334, 1967.

    Google Scholar 

  70. Stein, M. F., Kipnis, D. M., andDaughaday, W. H. The effect of human growth hormone on plasma insulin dynamics in man.J Lab Clin Med 60:1022, 1962.

    Google Scholar 

  71. Randle, P. J., Garland, P. B., Hales, C. N., andNewsholme, E. A. The glucose-fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.Lancet 1:785, 1963.

    Google Scholar 

  72. Coggeshall, L., andRoot, H. F. Acromegaly and diabetes mellitus.Endocrinology 26:1, 1940.

    Google Scholar 

  73. Karam, J. H., Grodsky, G. M., Pavlatos, F. C., andForsham, P. H. Critical factors in excessive serum-insulin response to glucose. Obesity in maturity-onset diabetes and growth hormone in acromegaly.Lancet 1:286, 1965.

    Google Scholar 

  74. Beck, P., Schalch, D. S., Parker, M. L., Kipnis, D. M., andDaughaday, W. H. Correlative studies of growth hormone and insulin plasma concentration with metabolic abnormalities in acromegaly.J Lab Clin Med 66:287, 1965.

    Google Scholar 

  75. Luft, R., andCerasi, E. Effect of human growth hormone on insulin production in panhypopituitarism.Lancet 2:124, 1964.

    Google Scholar 

  76. Stein, M. F., Kipnis, D. M., andDaughaday, W. H. The effect of human growth hormone on plasma insulin hemodynamics in man.J Lab Clin Med 60:1022, 1962.

    Google Scholar 

  77. Hernandez, A., Zorrilla, E., andGershberg, H. Decreased insulin production, elevated growth hormone levels and glucose intolerance in liver disease.J Lab Clin Med 73:25, 1969.

    Google Scholar 

  78. Conn, H. O., andDaughaday, W. H. Unpublished data.

  79. Remoin, D. L. Genetics of diabetes mellitus.Diabetes 16:346, 1967.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by the Irwin Strasburger Memorial Medical Foundation, New York, NY, and the Stratfield Fund, Bridgeport, Conn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conn, H.O., Schreiber, W., Elkington, S.G. et al. Cirrhosis and diabetes. Digest Dis Sci 14, 837–852 (1969). https://doi.org/10.1007/BF02233205

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02233205

Keywords

Navigation